Arfsten, Henrike <br/><br/>
GDF-15 in solid vs non-solid treatment-naïve malignancies.  [electronic resource] 

 -  European journal of clinical investigation  Nov 2019 
 - e13168 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2362 
<br/><br/><label>Standard No.: </label>10.1111/eci.13168  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenomedullin--blood<br/>Aged<br/>Breast Neoplasms--blood<br/>C-Reactive Protein--metabolism<br/>Cause of Death<br/>Endothelin-1--blood<br/>Female<br/>Gastrointestinal Neoplasms--blood<br/>Glycopeptides<br/>Growth Differentiation Factor 15--blood<br/>Humans<br/>Interleukin-6--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Mortality<br/>Myelodysplastic Syndromes--blood<br/>Myeloproliferative Disorders--blood<br/>Natriuretic Peptide, Brain--blood<br/>Neoplasm Metastasis<br/>Neoplasms--blood<br/>Peptide Fragments--blood<br/>Prognosis<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Protein Precursors--blood<br/>Serum Amyloid A Protein--metabolism<br/>Troponin T--blood